GlassScriptPhysician profile
Spencer A Coray
NPI 1013911619
$3,526.15
in general payments reported to CMS, 2019-2025
23 companies · $1,528 in 2025
The $1,528 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,397 · 2021: $165 · 2022: $121 · 2023: $192 · 2024: $123 · 2025: $1,528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,408 · Travel and Lodging: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,408.18 |
| Travel and Lodging | $435.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $1,157.96 | 2025 | Sx-One Microknife |
| Stryker Corporation | $1,138.30 | 2019 | |
| Polynovo North America LLC | $213.86 | 2023-2025 | Novosorb Btm |
| Depuy Synthes Sales INC. | $119.64 | 2021-2025 | Fms, Intrafix, Vapr |
| Zimvie INC. | $97.51 | 2022 | |
| Zimmer Biomet Holdings, INC. | $97.13 | 2019-2021 | |
| Avanos Medical | $96.88 | 2019-2025 | On-Q Pump and Accessories, On-Q* Pump and Accessories, Trivisc Sodium Hyaluronate |
| Bioventus LLC | $73.22 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $70.16 | 2019-2025 | Evenity, Prolia |
| Ferring Pharmaceuticals INC. | $66.65 | 2023-2024 | Euflexxa |
| Pacira Therapeutics, INC. | $60.37 | 2019 | |
| Fidia Pharma USA INC. | $49.23 | 2024-2025 | Hymovis, Triluron, Hyalgan |
| Linvatec Corporation | $46.59 | 2024-2025 | Biobrace 23mm, Linvatec Shoulder Arthroscopy, Livatec Knee Preservation System |
| Orthofix Medical, INC. | $37.43 | 2019-2024 | Physio-Stim |
| Djo, LLC | $29.79 | 2025 | Donjoy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $29.25 | 2019 | |
| Pfizer INC. | $27.11 | 2025 | |
| Davol INC. | $23.76 | 2022 | |
| Organogenesis INC. | $23.31 | 2021 | |
| Ethicon US, LLC | $19.41 | 2019 | |
| Mallinckrodt Enterprises LLC | $17.71 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.63 | 2019 | |
| Smith+Nephew, INC. | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Coray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.